Human TMEM2 is not a catalytic hyaluronidase, but a regulator of hyaluronan metabolism via HYBID (KIAA1199/CEMIP) and HAS2 expression
Journal of Biological Chemistry · 2023
DOI: 10.1016/j.jbc.2023.104826 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2023. Verfasst von Shinya Sato und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cosmetic Health Science, Gifu Pharmaceutical University, Gifu, Japan. Hauptthemen laut MEDLINE: Hyaluronic Acid, Hyaluronoglucosaminidase. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cutaneous hyaluronan (HA) is depolymerized to intermediate sizes in the extracellular matrix, and further fragmented in the regional lymph nodes. Previously, we showed that the HA-binding protein involved in HA depolymerization (HYBID), also known as KIAA1199/CEMIP, is responsible for the first step of HA depolymerization. Recently, mouse transmembrane 2 (mTMEM2) with high structural similarity to HYBID was proposed to be a membrane-bound hyaluronidase. However, we showed that the knockdown of human TMEM2 (hTMEM2) conversely promoted HA depolymerization in normal human dermal fibroblasts (NHDFs). Therefore, we examined the HA-degrading activity and function of hTMEM2 using HEK293T cells. We found that human HYBID and mTMEM2, but not hTMEM2, degraded extracellular HA, indicating that hTMEM2 does not function as a catalytic hyaluronidase. Analysis of the HA-degrading activity of chimeric TMEM2 in HEK293T cells suggested the importance of the mouse GG domain. Therefore, we focused on the amino acid residues that are conserved in active mouse and human HYBID and mTMEM2 but are substituted in hTMEM2. The HA-degrading activity of mTMEM2 was abolished when its His248 and Ala303 were simultaneously replaced by the corresponding residues of inactive hTMEM2 (Asn248 and Phe303). In NHDFs, enhancement of hTMEM2 expression by proinflammatory cytokines decreased HYBID expression and increased hyaluronan synthase 2-dependent HA production. The effects of proinflammatory cytokines were abrogated by hTMEM2 knockdown. A decreased HYBID expression by interleukin-1β and transforming growth factor-β was canceled by hTMEM2 knockdown. In conclusion, these results indicate that hTMEM2 is not a catalytic hyaluronidase, but a regulator of HA metabolism.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cosmetic Health Science, Gifu Pharmaceutical University, Gifu, Japan.
- Department of Biochemistry, School of Dentistry, Aichi Gakuin University, Nagoya, Aichi, Japan.
- Institute of Gene Research, Yamaguchi University Science Research Center, Ube, Yamaguchi, Japan.
- Department of Cell Growth and Tumor Regulation, Proteo-Science Center, Ehime University, Toon, Ehime, Japan; Department of Biochemistry and Molecular Genetics, Graduate School of Medicine, Ehime University, Toon, Ehime,…
- Department of Cosmetic Health Science, Gifu Pharmaceutical University, Gifu, Japan. Electronic address: inoshin@gifu-pu.ac.jp.
Zitieren
APA
Sato, S., Miyazaki, M., Fukuda, S., Mizutani, Y., Mizukami, Y., Higashiyama, S., & Inoue, S. (2023). Human TMEM2 is not a catalytic hyaluronidase, but a regulator of hyaluronan metabolism via HYBID (KIAA1199/CEMIP) and HAS2 expression. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2023.104826
Vancouver
Sato S, Miyazaki M, Fukuda S, Mizutani Y, Mizukami Y, Higashiyama S, et al. Human TMEM2 is not a catalytic hyaluronidase, but a regulator of hyaluronan metabolism via HYBID (KIAA1199/CEMIP) and HAS2 expression. Journal of Biological Chemistry. 2023. doi:10.1016/j.jbc.2023.104826
BibTeX
@article{Sato2023,
author = {Sato, Shinya and Miyazaki, Megumi and Fukuda, Shinji and Mizutani, Yukiko and Mizukami, Yoichi and Higashiyama, Shigeki and Inoue, Shintaro},
title = {Human TMEM2 is not a catalytic hyaluronidase, but a regulator of hyaluronan metabolism via HYBID (KIAA1199/CEMIP) and HAS2 expression},
journal = {Journal of Biological Chemistry},
year = {2023},
doi = {10.1016/j.jbc.2023.104826}
}
EUVIMED